Related Experiment Videos
Hu Ly-M3--a human leukocyte antigen
Transplantation
|October 1, 1983
Summary
A new monoclonal antibody, 5-4.8, identifies a leukocyte-specific glycoprotein determinant, Hu Ly-m3, on human lymphocytes. This discovery aids in understanding immune cell surface markers and their potential diagnostic applications.
Area of Science:
- Immunology
- Cell Biology
- Biochemistry
Background:
- Monoclonal antibodies are crucial tools for identifying cell surface markers.
- Human peripheral blood lymphocytes include T cells, B cells, and null cells, each with distinct surface protein expressions.
Purpose of the Study:
- To produce and characterize a monoclonal antibody that targets a specific determinant on human lymphocytes.
- To determine the specificity and nature of the identified determinant (Hu Ly-m3).
Main Methods:
- Production of monoclonal antibody 5-4.8 against human peripheral blood lymphocytes.
- Testing antibody reactivity across various human cell types (lymphocytes, thymocytes, spleen, bone marrow, granulocytes, platelets) and non-hematopoietic cells (heart, liver, kidney).
- Affinity to lentil-lectin and molecular weight analysis to characterize the Hu Ly-m3 determinant.
Main Results:
- Monoclonal antibody 5-4.8 demonstrated leukocyte specificity, reacting with T, B, and null lymphocytes from 40 individuals.
- The antibody also reacted with thymocytes, spleen cells, bone marrow cells (30%), and weakly with granulocytes and platelets.
- Hu Ly-m3 was identified as a 47,000-dalton single-chain glycoprotein, distinct from HLA antigens.
Conclusions:
- The monoclonal antibody 5-4.8 recognizes a novel, leukocyte-specific cell surface glycoprotein determinant, Hu Ly-m3.
- Hu Ly-m3 is present on various immune cells but absent from non-hematopoietic tissues, distinguishing it from HLA.
- This antibody provides a valuable tool for immunophenotyping and studying human leukocyte populations.